Researchers Fret as Social Media Lift Veil on Drug Trials

Drug makers and researchers are increasingly concerned that online chatter could unravel the carefully built construct of the clinical trial, and perhaps put patients in danger. They worry that patients may drop out if they suspect they aren't getting the drug being tested, or may report symptoms inaccurately because of the influence or suggestions of others in the trial.

Link to the full article

Originally published in The Wall Street Journal